YOLFTbeta
PT Soho Global Health Tbk

PT Soho Global Health Tbk

SOHO · JK · Healthcare / Medical Distribution

1,135.00IDR-85.00 (-6.97%)

Price History

Full chart

Market Stats

Previous Close1,220.00
Open1,220.00
Day Range1,135.00 – 1,225.00
52-Week Range752.28 – 3,904.40
Volume44.90K
Market Cap17.83T
P/E (TTM)25.43
Forward P/E0.00
EPS55.26
Dividend Yield5.50%
Beta0.84
50-Day Avg1,320.40
200-Day Avg1,712.68

About

PT Soho Global Health Tbk, together with its subsidiaires, operates as a healthcare company in Indonesia. It operates through Distributions, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and distribution and logistics services. It also offers body defense, stamina and vitality, brain nutrient, eye health, skin care, weight management, and wellness products; sells and markets medical devices and medical equipment products in the areas of wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics; and provides product registration, marketing intelligence, sales, and marketing support services. In addition, it provides contract manufacturing services for various dosage forms. The company was founded in 1946 and is headquartered in Jakarta, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Harry Salam
  • Employees2.33K
  • HeadquartersJl. Rawa Sumur II Kav. BB No. 3, Jakarta, Indonesia, 13930, Indonesia
  • Websitehttps://www.sohoglobalhealth.com

Leadership

  • Mr. Harry SalamPresident Director · b. 1965
  • Mr. Pandy HariantoSenior VP, COO-Operations & Director · b. 1977
  • Ms. Yuliana TjhaiSenior EVP of Legal, Compliance, Internal Audit, Corporate Secretary & Human Resources and Director · b. 1981
  • Raymond M. SimanungkalitHead of Alliance
  • Mr. Devy HeriyantoHead of Internal Audit Unit · b. 1985

Financials

Income Statement

Currency: IDR2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.05T4.56T5.05T6.16T7.08T7.29T8.20T10.06T10.78T
Growth (%)-+12.74%+10.63%+22.10%+14.80%+3.02%+12.45%+22.69%+7.17%
Cost of Revenue3.24T3.70T4.06T4.82T5.51T5.95T6.91T8.52T9.02T
Gross Profit803.74B867.63B990.05B1.35T1.57T1.34T1.29T1.54T1.75T
Gross Margin19.86%19.01%19.61%21.84%22.18%18.36%15.74%15.32%16.28%
Operating Expense727.69B753.73B769.75B1.09T891.23B894.73B851.39B969.59B1.03T
Operating Income76.04B113.90B220.31B259.84B678.12B443.66B438.67B571.25B728.44B
Operating Margin1.88%2.50%4.36%4.22%9.58%6.09%5.35%5.68%6.76%
EBITDA124.98B161.36B295.83B335.65B762.81B525.12B538.95B638.55B820.75B
EBITDA Margin3.09%3.54%5.86%5.45%10.78%7.20%6.57%6.35%7.61%
Net Income33.30B49.39B118.46B172.11B550.18B356.73B371.34B462.65B600.32B
Net Income Margin0.82%1.08%2.35%2.79%7.78%4.89%4.53%4.60%5.57%
R&D13.67B13.01B14.66B18.12B23.26B22.40B22.61B25.49B26.52B
R&D as % of Total Revenue0.34%0.29%0.29%0.29%0.33%0.31%0.28%0.25%0.25%
Interest Expense5.61B7.13B61.25B19.50B5.05B4.35B4.92B6.93B3.38B
Interest Expense % of Total Revenue0.14%0.16%1.21%0.32%0.07%0.06%0.06%0.07%0.03%

Balance Sheet

Currency: IDR2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.72T2.79T3.27T4.18T4.02T4.47T4.75T5.41T6.16T
Total Liabilities1.57T1.58T1.96T1.97T1.81T2.05T2.35T2.70T3.57T
Total Equity1.15T1.21T1.31T2.20T2.21T2.43T2.40T2.72T2.58T
Cash315.80B274.42B263.06B903.57B953.30B1.13T688.47B422.45B1.10T
Total Debt452.88B482.04B514.21B123.37B24.15B21.02B19.95B14.87B7.22B
Net Debt137.09B207.63B251.16B-780.20B-929.15B-1.11T-668.52B-407.58B-1.10T

Cash Flow

Currency: IDR2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow123.48B-28.69B9.53B577.81B630.49B356.73B211.13B-110.46B917.84B
Investing Cash Flow-190.73B-8.82B-13.56B-18.73B-6.38B-48.18B-232.90B11.27B72.69B
Financing Cash Flow12.12B-3.87B-7.34B-42.76B-559.01B-147.19B-416.59B-166.83B-308.85B
Capital Expenditure196.37B21.25B31.58B45.61B36.63B50.33B38.75B108.41B56.86B
Free Cash Flow-72.88B-49.95B-22.05B532.20B593.86B306.40B172.38B-218.87B860.98B
Dividends Paid-3.87B7.34B13.48B549.55B149.76B399.79B152.30B300.79B
FCF to OCF-59.02%174.06%-231.33%92.11%94.19%85.89%81.65%198.14%93.81%
Dividend Paid to FCF--7.74%-33.28%2.53%92.54%48.88%231.93%-69.59%34.94%

Earnings

Report DateSep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate------------
EPS Actual-61.2417.82103.18119.70181.2229.39113.7738.5974.3554.3645.0675.92
Surprise------------
Timing------------

Key Statistics & Ratios

Market Cap17.83T
Enterprise Value17.43T
Trailing P/E25.43
Forward P/E0.00
Price / Sales1.63
Price / Book7.39
EPS55.26
Book Value193.40
Revenue (TTM)10.97T
Gross Profit (TTM)1.99T
EBITDA908.48B
Profit Margin6.22%
Operating Margin8.34%
Return on Equity26.47%
Return on Assets9.67%
Shares Outstanding12.69B
Shares Float1.17B
Beta0.84
Dividend Yield5.50%
Dividend Rate72.60
Payout Ratio135.70%

Dividends

20262×
39.50Jun 2, 202633.10Jan 7, 2026
20251×
23.70Jun 10, 2025
20241×
12.00Jul 9, 2024
20232×
1.97Nov 13, 202311.80Jul 7, 2023
20221×
11.80Oct 25, 2022
20213×
19.70Aug 12, 202123.60May 17, 2021100000.00May 11, 2021

Stock Splits

  • Nov 13, 202310:1